172 related articles for article (PubMed ID: 9309373)
1. Fleroxacin 400 mg once daily versus ofloxacin 400 mg twice daily in skin and soft tissue infections.
Drehobl M; Koenig L; Barker M; St Clair P; Maladorno D
Chemotherapy; 1997; 43(5):378-84. PubMed ID: 9309373
[TBL] [Abstract][Full Text] [Related]
2. Once-daily oral gatifloxacin versus oral levofloxacin in treatment of uncomplicated skin and soft tissue infections: double-blind, multicenter, randomized study.
Tarshis GA; Miskin BM; Jones TM; Champlin J; Wingert KJ; Breen JD; Brown MJ
Antimicrob Agents Chemother; 2001 Aug; 45(8):2358-62. PubMed ID: 11451697
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy and safety of oral fleroxacin and amoxicillin/clavulanate potassium in skin and soft tissue infections.
Tassler H
Am J Med; 1993 Mar; 94(3A):159S-165S. PubMed ID: 8452174
[TBL] [Abstract][Full Text] [Related]
4. Open trial of oral fleroxacin versus amoxicillin/clavulanate in the treatment of infections of skin and soft tissue.
Powers RD
Am J Med; 1993 Mar; 94(3A):155S-158S. PubMed ID: 8452173
[TBL] [Abstract][Full Text] [Related]
5. A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection.
Schrenzel J; Harbarth S; Schockmel G; Genné D; Bregenzer T; Flueckiger U; Petignat C; Jacobs F; Francioli P; Zimmerli W; Lew DP;
Clin Infect Dis; 2004 Nov; 39(9):1285-92. PubMed ID: 15494904
[TBL] [Abstract][Full Text] [Related]
6. Comparison of oral fleroxacin with oral amoxicillin/clavulanate for treatment of skin and soft tissue infections.
Smith JW; Nichols RL
Am J Med; 1993 Mar; 94(3A):150S-154S. PubMed ID: 8452172
[TBL] [Abstract][Full Text] [Related]
7. A multicentre, double-blind, randomised study comparing the efficacy and safety of oral levofloxacin versus ciprofloxacin in the treatment of uncomplicated skin and skin structure infections.
Nicodemo AC; Robledo JA; Jasovich A; Neto W
Int J Clin Pract; 1998 Mar; 52(2):69-74. PubMed ID: 9624783
[TBL] [Abstract][Full Text] [Related]
8. Fleroxacin. A review of its pharmacology and therapeutic efficacy in various infections.
Balfour JA; Todd PA; Peters DH
Drugs; 1995 May; 49(5):794-850. PubMed ID: 7601015
[TBL] [Abstract][Full Text] [Related]
9. Once-daily fleroxacin versus twice-daily ciprofloxacin in the treatment of complicated urinary tract infections.
Frankenschmidt A; Naber KG; Bischoff W; Kullmann K
J Urol; 1997 Oct; 158(4):1494-9. PubMed ID: 9302150
[TBL] [Abstract][Full Text] [Related]
10. Ofloxacin treatment of difficult infections of the skin and skin structure.
Gentry LO; Rodriguez-Gomez G
Cutis; 1993 Jan; 51(1):55-8. PubMed ID: 8419113
[TBL] [Abstract][Full Text] [Related]
11. Fleroxacin versus ofloxacin in patients with complicated urinary tract infection: a controlled clinical study.
Naber KG; Sigl G
Am J Med; 1993 Mar; 94(3A):114S-117S. PubMed ID: 8452166
[TBL] [Abstract][Full Text] [Related]
12. A pilot study of oral fleroxacin once daily compared with conventional therapy in patients with pyogenic liver abscess.
Chen YW; Chen YS; Lee SS; Yen MY; Wann SR; Lin HH; Huang WK; Liu YC
J Microbiol Immunol Infect; 2002 Sep; 35(3):179-83. PubMed ID: 12380791
[TBL] [Abstract][Full Text] [Related]
13. Systemic antimicrobial therapy for skin and skin structure infections: comparison of fleroxacin and ceftazidime.
Parish LC; Jungkind DL
Am J Med; 1993 Mar; 94(3A):166S-173S. PubMed ID: 8452175
[TBL] [Abstract][Full Text] [Related]
14. Complicated urinary infection in spinal injury patients: fleroxacin compared with ciprofloxacin.
Whitby M; Angus L; Nimmo G; Hill V
Chemotherapy; 1996; 42(6):468-72. PubMed ID: 8957583
[TBL] [Abstract][Full Text] [Related]
15. Once-daily use of ofloxacin for prophylaxis in breast cancer surgery.
Morimoto K; Kinoshita H
Chemotherapy; 1998; 44(2):135-41. PubMed ID: 9551245
[TBL] [Abstract][Full Text] [Related]
16. A pilot study of oral fleroxacin given once daily in patients with bone and joint infections.
Putz PA
Am J Med; 1993 Mar; 94(3A):177S-181S. PubMed ID: 8452177
[TBL] [Abstract][Full Text] [Related]
17. Treatment of posttraumatic osteitis with intravenous ofloxacin.
Seibold R; Betz A
Clin Ther; 1991; 13(4):457-9. PubMed ID: 1933996
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of ofloxacin otic solution once daily for 7 days in the treatment of otitis externa: a multicenter, open-label, phase III trial.
Torum B; Block SL; Avila H; Montiel F; Oliva A; Quintanilla W; Duncanson F; Cantrell HF; Riefler J; Katz E; Lombardy E
Clin Ther; 2004 Jul; 26(7):1046-54. PubMed ID: 15336469
[TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of oral levofloxacin 500 mg once-daily dosage for treatment of lower respiratory tract infections and urinary tract infections: a prospective multicenter study in China.
Zhang YY; Huang HH; Ren ZY; Zheng HG; Yu YS; Lü XJ; Xiao ZK; Yang HF; Xiu QY; Chen BY; Yue HM; Hao QL; Huang JA; Ma H; Xiao W; Guo DY; Si B; Sun SH; Zhang W; Li QH; Shen HH; Duan J; Li HY; Yao WZ; Gu JM; Xia QM; Ying KJ; Liu A; Yang HP; Shi MH; Sun TY; Ding GH; Wu GM
J Infect Chemother; 2009 Oct; 15(5):301-11. PubMed ID: 19856068
[TBL] [Abstract][Full Text] [Related]
20. Fleroxacin versus norfloxacin for oral treatment of serious urinary tract infections.
Childs SJ
Am J Med; 1993 Mar; 94(3A):105S-107S. PubMed ID: 8452164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
